Literature DB >> 35918492

[64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation.

Fang Xie1, Weijun Wei2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35918492     DOI: 10.1007/s00259-022-05887-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  71 in total

Review 1.  Peripheral benzodiazepine receptors: on mice and human brain imaging.

Authors:  Ben Avi Weissman; Lily Raveh
Journal:  J Neurochem       Date:  2003-02       Impact factor: 5.372

2.  TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.

Authors:  Marcus Unterrainer; C Mahler; L Vomacka; S Lindner; J Havla; M Brendel; G Böning; B Ertl-Wagner; T Kümpfel; V M Milenkovic; R Rupprecht; M Kerschensteiner; P Bartenstein; Nathalie L Albert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-09       Impact factor: 9.236

3.  PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET.

Authors:  Sriram Venneti; Brian J Lopresti; Guoji Wang; Ronald L Hamilton; Chester A Mathis; William E Klunk; Udayan M Apte; Clayton A Wiley
Journal:  Neurobiol Aging       Date:  2008-02-21       Impact factor: 4.673

4.  [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

Authors:  A L Bartels; A T M Willemsen; J Doorduin; E F J de Vries; R A Dierckx; K L Leenders
Journal:  Parkinsonism Relat Disord       Date:  2009-05-31       Impact factor: 4.891

Review 5.  Imaging microglial activation in Huntington's disease.

Authors:  Yen F Tai; Nicola Pavese; Alexander Gerhard; Sarah J Tabrizi; Roger A Barker; David J Brooks; Paola Piccini
Journal:  Brain Res Bull       Date:  2006-11-27       Impact factor: 4.077

Review 6.  PET imaging of neuroinflammation in neurological disorders.

Authors:  William C Kreisl; Min-Jeong Kim; Jennifer M Coughlin; Ioline D Henter; David R Owen; Robert B Innis
Journal:  Lancet Neurol       Date:  2020-11       Impact factor: 44.182

Review 7.  Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.

Authors:  Lingling Zhang; Kuan Hu; Tuo Shao; Lu Hou; Shaojuan Zhang; Weijian Ye; Lee Josephson; Jeffrey H Meyer; Ming-Rong Zhang; Neil Vasdev; Jinghao Wang; Hao Xu; Lu Wang; Steven H Liang
Journal:  Acta Pharm Sin B       Date:  2020-08-25       Impact factor: 11.413

Review 8.  Supervised clustering for TSPO PET imaging.

Authors:  Julia Schubert; Matteo Tonietto; Federico Turkheimer; Paolo Zanotti-Fregonara; Mattia Veronese
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-29       Impact factor: 9.236

Review 9.  PET imaging of inflammation biomarkers.

Authors:  Chenxi Wu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2013-06-24       Impact factor: 11.556

10.  TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis.

Authors:  Lena Vomacka; Nathalie Lisa Albert; Simon Lindner; Marcus Unterrainer; Christoph Mahler; Matthias Brendel; Larissa Ermoschkin; Astrid Gosewisch; Anika Brunegraf; Christopher Buckley; Tania Kümpfel; Rainer Rupprecht; Sibylle Ziegler; Martin Kerschensteiner; Peter Bartenstein; Guido Böning
Journal:  EJNMMI Res       Date:  2017-10-26       Impact factor: 3.138

View more
  1 in total

1.  Pulmonary artery imaging with 68 Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Juan-Ni Gong; Bi-Xi Chen; Hai-Qun Xing; Li Huo; Yuan-Hua Yang; Min-Fu Yang
Journal:  J Nucl Cardiol       Date:  2022-08-04       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.